Deprivation of arginine by recombinant human arginase in prostate cancer cells.
about
Targeting innate immunity for neurodegenerative disorders of the central nervous systemAutophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy.Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy.Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivationArginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target.Recombinant human arginase induced caspase-dependent apoptosis and autophagy in non-Hodgkin's lymphoma cellsAmino Acid Profiles of Serum and Urine in Search for Prostate Cancer Biomarkers: a Pilot Study.Drug-induced amino acid deprivation as strategy for cancer therapy.Molecular basis and current strategies of therapeutic arginine depletion for cancer.Arginine dependence of tumor cells: targeting a chink in cancer's armor.The role of autophagy in the cytotoxicity induced by recombinant human arginase in laryngeal squamous cell carcinoma.Three-dimensional environment renders cancer cells profoundly less susceptible to a single amino acid starvation.Involvement of autophagy in recombinant human arginase-induced cell apoptosis and growth inhibition of malignant melanoma cells.The Metabolic Phenotype of Prostate Cancer.Vincristine could partly suppress stromal support to T-ALL blasts during pegylated arginase I treatment.Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma.Arginine auxotrophic gene signature in paediatric sarcomas and brain tumours provides a viable target for arginine depletion therapies.Expression, purification, and biochemical properties of arginase from Bacillus subtilis 168.Linking cellular metabolism and metabolomics to risk-stratification of prostate cancer clinical aggressiveness and potential therapeutic pathwaysSensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes
P2860
Q26744219-2FCA6364-0307-46F0-8883-68E69BD15C38Q33839054-37313900-2757-4ED1-ABB8-3A71C17D9BDDQ34314481-E96F278B-BFA9-407C-9145-24F4C0E7FBA4Q34568337-EE2BD96D-C020-4DAC-A764-B39CFD0343FEQ35561304-9CC12352-42E0-45BE-88AD-839189B0034AQ37299640-DC2E4958-8998-4708-8D42-474293DF0EE0Q37612851-7C812640-0813-48F0-81F3-4A6EAD9082F8Q38657061-25E81071-C13D-49E2-AB98-3CA9811EA2ECQ38749541-00136E92-1806-4D63-AB79-7FDA85C52F11Q38816145-029AD3C2-BC69-4D24-BBDA-D950EC4BC80EQ38883330-503AA7BC-066E-40F3-A8D8-146C99FE65CBQ39095939-2BFD1AD8-BA49-47F8-9B39-2DAB103D0C16Q39114980-664D3723-E1D5-4966-AD8B-DFA28AB3F995Q39412872-5C5362C3-FA28-493B-BA8F-2FE1CB8D51DBQ40739842-540E5B12-C86E-46D3-9F3F-52BA7316ED2BQ41457918-B12A8C2B-AF87-4B6B-A5F4-EBB2686014FFQ42362675-F97D73A7-9FFC-435F-93B5-65628E80766EQ51034440-CE0870C4-3AE6-497F-A9F3-273ED3E50C80Q58562101-84C434D7-2CCA-46F6-8720-73ABD3B9BCEFQ58782876-4538D910-EBB8-4803-AA01-5492930C212F
P2860
Deprivation of arginine by recombinant human arginase in prostate cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Deprivation of arginine by recombinant human arginase in prostate cancer cells.
@en
type
label
Deprivation of arginine by recombinant human arginase in prostate cancer cells.
@en
prefLabel
Deprivation of arginine by recombinant human arginase in prostate cancer cells.
@en
P2093
P2860
P356
P1476
Deprivation of arginine by recombinant human arginase in prostate cancer cells.
@en
P2093
Chung-Tsen Hsueh
Eddy C Hsueh
Paul Ning-Man Cheng
Stephanie M Knebel
Wai-Hung Lo
Yun-Chung Leung
P2860
P2888
P356
10.1186/1756-8722-5-17
P577
2012-04-30T00:00:00Z
P5875
P6179
1041830204